Welcome to our dedicated page for Neogen SEC filings (Ticker: NEOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Neogen Corporation SEC filings document material events for an operating company focused on food safety and animal safety products. Recent 8-K filings cover quarterly results and financial condition, Regulation FD disclosures related to Petrifilm manufacturing validation, and exhibits containing earnings releases and business updates.
The company’s filings also record governance and leadership matters, including executive appointments and departures, compensatory arrangements, board committee assignments, annual meeting voting results, executive compensation votes, and auditor ratification. These disclosures provide formal records of Neogen’s public-company reporting, operating updates, governance structure and shareholder matters.
Insider stock vesting and sale by former COO
On 10/07/2025, Douglas Edward Jones, identified as a former COO and officer of Neogen Corp (NEOG), had 12,940 restricted stock units (RSUs) vest and be settled for 12,940 shares of common stock at an indicated per‑share value of $5.63. The Form 4 shows two linked non‑derivative transactions on that date: a grant/settlement code M acquiring 12,940 shares and a disposition code F disposing of 6,329 shares at $5.63. After these reported transactions, Mr. Jones beneficially owned 88,458 shares (direct).
The filing states each RSU equals one share and that vesting and settlement occurred on 10/07/2025. The form is signed by an attorney‑in‑fact on 10/09/2025.
Insider stock activity at NEOGEN (NEOG): Former CEO and officer John Edward Adent had 32,936 restricted stock units vest on 10/07/2025, which were settled into 32,936 shares of common stock at an effective price of $5.63 per share. On the same date, 9,297 shares were disposed of at $5.63, leaving 330,651 shares beneficially owned after the transactions. The filing was signed by an attorney-in-fact on 10/09/2025.
Catherine E. Woteki, a director of NEOGEN CORP (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of common stock on 10/07/2025. The RSUs were settled at a reported per-share value of $5.63, and following the transaction the reporting person beneficially owned 15,315 shares.
The filing is a routine Section 16 Form 4 reporting the vesting and settlement of equity compensation; it shows an increase in the director’s direct holdings but does not disclose any cash sale or purchase beyond the RSU settlement.
Tobin James P, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest on 10/07/2025 and those RSUs were settled into 2,071 shares of common stock at a recorded price of $5.63 per share. After the settlement, the reporting person beneficially owned 39,545 shares directly. The Form 4 shows this as an acquisition resulting from compensation vesting rather than an open-market purchase.
NEOGEN CORP (NEOG) director Rafael A. Rodriguez received 2,071 restricted stock units that vested and were settled into 2,071 shares of common stock on 10/07/2025. The reported per-share value on the transaction is $5.63, and Mr. Rodriguez's total beneficial ownership after the settlement is 17,019 shares held directly. The filing is a Form 4 disclosure of an insider vesting event rather than a market purchase or sale.
Ashima Gupta, a director of Neogen Corporation (NEOG), reported the vesting and settlement of 2,071 restricted stock units (RSUs) into 2,071 shares of common stock on 10/07/2025. The reported per‑share value recorded on the form is $5.63, and the reporting form shows 23,988 shares beneficially owned by the reporting person following this transaction.
The filing is a routine Section 16 disclosure showing compensation‑related equity vesting rather than an open‑market buy or sell. The form was signed by an attorney‑in‑fact on 10/09/2025.
Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on 10/07/2025 and those RSUs were settled into an equal number of shares of common stock at an effective price of $5.63 per share. After the settlement, Mr. Green directly owned 14,852 shares. The Form 4 was signed by an attorney-in-fact on 10/09/2025. The filing records a routine equity compensation settlement rather than an open-market purchase or sale.
Jeffrey D. Capello, a director of Neogen Corporation (NEOG), had 2,071 restricted stock units vest and settle on 10/07/2025.
The settlement converted the RSUs into 2,071 shares of common stock at an indicated unit price of $5.63, bringing his total beneficial ownership to 28,700 shares following the transaction.
Insider report: A director of Neogen Corporation (NEOG) had 2,071 restricted stock units vest and be settled for 2,071 shares of common stock on 10/07/2025. The transaction is recorded as a vesting/settlement (code M) with an indicated price of $5.63 per share. After the settlement the reporting person beneficially owned 92,545 shares. The Form 4 was signed on 10/09/2025.
William T. Boehm, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest and be settled into 2,071 shares of Common Stock on 10/07/2025 at a reported per‑share value of $5.63. After the transaction Mr. Boehm beneficially owns 38,285 shares directly. The Form 4 was signed by an attorney‑in‑fact on 10/09/2025.